Navamedic Financial Statements From 2010 to 2024
| NAVA Stock | NOK 24.50 0.50 2.00% |
Check Navamedic ASA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Navamedic ASA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Navamedic financial statements analysis is a perfect complement when working with Navamedic ASA Valuation or Volatility modules.
Navamedic |
Navamedic ASA Company Return On Equity Analysis
Navamedic ASA's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Navamedic ASA Return On Equity | 0.073 |
Most of Navamedic ASA's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Navamedic ASA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Navamedic ASA has a Return On Equity of 0.073. This is 100.3% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The return on equity for all Norway stocks is 123.55% lower than that of the firm.
Navamedic ASA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Navamedic ASA's current stock value. Our valuation model uses many indicators to compare Navamedic ASA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Navamedic ASA competition to find correlations between indicators driving Navamedic ASA's intrinsic value. More Info.Navamedic ASA is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.87 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Navamedic ASA is roughly 1.15 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Navamedic ASA's earnings, one of the primary drivers of an investment's value.About Navamedic ASA Financial Statements
Navamedic ASA investors utilize fundamental indicators, such as revenue or net income, to predict how Navamedic Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway. NAVAMEDIC ASA operates under Healthcare Products classification in Norway and is traded on Oslo Stock Exchange. It employs 26 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Navamedic Stock
Navamedic ASA financial ratios help investors to determine whether Navamedic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Navamedic with respect to the benefits of owning Navamedic ASA security.